U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

HERACLEUM HEMSLEYANUM WHOLE

MORE DETAILS

G3X356J02F

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Pain Relief Cream by QINGDAO HAINUO BIOLOGICAL ENGINEERING CO., LTD.
(2022)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d87138f-5979-4e23-bd9e-ce96df1bd6f0
First approved in 2022
Source:
Pain Relief Cream by QINGDAO HAINUO BIOLOGICAL ENGINEERING CO., LTD.
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d87138f-5979-4e23-bd9e-ce96df1bd6f0
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966